Moderna and Merck’s cancer vaccine reduced the risk of melanoma recurrence or death by 42%, but investors questioned its ...

Bloom Energy reported 94 cents of earnings per share on $1.24 billion in revenue, beating expectations. The stock was sliding ...

Telecom stocks are under siege, and the enemy is SpaceX. But shares of T-Mobile, AT&T, and others look attractively priced.

Berkshire participated in Alphabet’s $85 billion equity fund deal in June that could be a model for any Meta equity raise.

Telecom stocks are tumbling on news that SpaceX is aiming to secure 80,000 cell sites across the US, raising the specter of ...

Tariff refunds boosted Tesla’s third-quarter numbers. Barring those, an analyst says, the EV maker would’ve missed across the ...

Caterpillar is viewed by J.P. Morgan as “the biggest winner of an extended U.S. construction cycle,” though it’s had a rough ...

SpaceX is working to secure access to cell towers just weeks after buying more wireless spectrum. It’s upending wireless ...

The prohibitions could cut off Big Pharma from Chinese biotechs—the source of many promising cancer treatments ...

Thursday evening, Newmont announced earnings per share of $2.20 from sales of $6.4 billion. Wall Street was looking for $1.96 ...

Some investors are looking beyond turmoil in France for companies that depend little on their domestic market.

SpaceX stock is trying to end a wild week of trading in the green. An upgrade from Phillip Securities is helping.